NTRA
Natera, Inc.
Price Chart
Latest Quote
$228.80
-2.61 (-1.13%)
Current Price
| Previous Close | $231.41 |
| Open | $231.52 |
| Day High | $234.13 |
| Day Low | $219.58 |
| Volume | 1,577,675 |
Stock Information
| Shares Outstanding | 143.22M |
| Total Debt | $240.08M |
| Cash Equivalents | $1.09B |
| Revenue | $2.50B |
| Net Income | $-226.32M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $33.62B |
| EPS (TTM) | $-1.62 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $31.92B |
| Sales | $2.50B |
| Income | $-226.32M |
| Book/sh | $12.43 |
| Cash/sh | $7.60 |
| Employees | 6K |
Financial Ratios
| Quick Ratio | 2.70 |
| Current Ratio | 2.96 |
| Debt/Eq | 13.53 |
Returns & Margins
| ROA | -9.12% |
| ROE | -15.02% |
| Gross Margin | 65.07% |
| Operating Margin | -12.39% |
| Profit Margin | -9.05% |
Ownership
| Insider Ownership | 3.02% |
| Institutional Ownership | 95.82% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1126.60 |
| P/S | 13.44 |
| P/B | 18.89 |
Analyst Data
| Recommendation | buy |
| Target Price | $259.05 |
Technical Indicators
| SMA20 | $218.24 |
| SMA50 | $209.23 |
| SMA200 | $207.22 |
| RSI | 65.04 |
| ATR | 11.4096 |
| Shares Float | 138.91M |
| Short Float | 2.60% |
| Short Ratio | 2.06 |
| Volatility | 1.54 |
| Rel Volume | 1.11 |
Performance History
| Week | +8.20% |
| Month | +15.25% |
| Quarter | +17.33% |
| 6 Months | +4.46% |
| YTD | +2.59% |
| Year | +36.60% |
| 3 Years | +362.85% |
| 5 Years | +131.70% |
| 10 Years | +1642.84% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $234.76 | 1,564,806 |
| 2026-06-22 | $228.80 | 1,577,700 |
| 2026-06-18 | $231.41 | 2,630,800 |
| 2026-06-17 | $226.44 | 1,777,300 |
| 2026-06-16 | $220.11 | 1,378,800 |
| 2026-06-15 | $216.97 | 1,017,200 |
| 2026-06-12 | $212.07 | 811,700 |
| 2026-06-11 | $219.23 | 736,000 |
| 2026-06-10 | $216.50 | 1,026,300 |
| 2026-06-09 | $222.82 | 1,210,900 |
| 2026-06-08 | $213.47 | 1,115,200 |
| 2026-06-05 | $215.31 | 849,100 |
| 2026-06-04 | $222.10 | 1,266,700 |
| 2026-06-03 | $211.85 | 1,463,500 |
| 2026-06-02 | $212.73 | 1,174,600 |
| 2026-06-01 | $218.81 | 1,334,300 |
| 2026-05-29 | $223.37 | 2,690,800 |
| 2026-05-28 | $213.94 | 1,861,900 |
| 2026-05-27 | $203.11 | 1,273,000 |
| 2026-05-26 | $200.91 | 1,466,300 |
About Natera, Inc.
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
đ° Latest News
Natera (NTRA) Stock Fair Value Edges Lower As MRD And Signatera Debate Splits Analysts
Simply Wall St. âĸ 2026-06-23T18:16:21Z
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as AI Spending Concerns Weigh on Technology Shares
MT Newswires âĸ 2026-06-23T13:19:21ZNatera (NTRA), CytoDyn Announce Strategic Collaboration for ctDNA-Guided mCRC Clinical Trials
Insider Monkey âĸ 2026-06-17T13:45:59Z
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
StockStory âĸ 2026-06-16T14:09:04Z
Goldman Sachs Initiates Coverage on Natera, Inc. (NTRA)
Insider Monkey âĸ 2026-06-16T12:51:36Z
1 Cash-Heavy Stock on Our Buy List and 2 We Avoid
StockStory âĸ 2026-06-15T12:04:07Z
Forget SpaceX Hype: Billionaire Stanley Druckenmiller is Loading Up on This Unknown Healthcare Stock
Insider Monkey âĸ 2026-06-13T13:49:50Z
Natera MRD Leadership Supported by 'Durable' High-Value Market, RBC Says
MT Newswires âĸ 2026-06-12T15:32:17ZNTRA & CytoDyn Partner to Advance ctDNA-Guided Development in mCRC
Zacks âĸ 2026-06-08T15:48:00Z
Natera Pushes MRD And Panorama Into Treatment Guiding Roles
Simply Wall St. âĸ 2026-06-08T15:11:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $771,169,000 | $642,785,000 | $565,734,000 | $456,256,000 |
| Cost Of Revenue | $812,933,000 | $673,753,000 | $589,831,000 | $456,256,000 |
| Total Revenue | $2,306,113,000 | $1,696,911,000 | $1,082,571,000 | $820,222,000 |
| Operating Revenue | $2,306,113,000 | $1,696,911,000 | $1,082,571,000 | $820,222,000 |
| Expenses | ||||
| Interest Expense | $4,069,000 | $10,685,000 | $12,638,000 | $9,319,000 |
| Total Expenses | $2,616,024,000 | $1,919,205,000 | $1,528,816,000 | $1,361,262,000 |
| Net Non Operating Interest Income Expense | $41,822,000 | $32,563,000 | $11,715,000 | $-5,781,000 |
| Interest Expense Non Operating | $4,069,000 | $10,685,000 | $12,638,000 | $9,319,000 |
| Operating Expense | $1,803,091,000 | $1,245,452,000 | $938,985,000 | $905,006,000 |
| Other Income Expense | - | - | - | - |
| Other Non Operating Income Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Net Interest Income | $41,822,000 | $32,563,000 | $11,715,000 | $-5,781,000 |
| Interest Income | $45,891,000 | $43,248,000 | $24,353,000 | $3,538,000 |
| Normalized Income | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Net Income From Continuing And Discontinued Operation | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Total Operating Income As Reported | $-309,911,000 | $-222,294,000 | $-446,245,000 | $-541,040,000 |
| Net Income Common Stockholders | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Net Income | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Net Income Including Noncontrolling Interests | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Net Income Continuous Operations | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Pretax Income | $-268,089,000 | $-189,731,000 | $-434,530,000 | $-546,821,000 |
| Interest Income Non Operating | $45,891,000 | $43,248,000 | $24,353,000 | $3,538,000 |
| Operating Income | $-309,911,000 | $-222,294,000 | $-446,245,000 | $-541,040,000 |
| Depreciation Amortization Depletion Income Statement | $1,720,000 | $0 | $0 | - |
| Depreciation And Amortization In Income Statement | $1,720,000 | $0 | $0 | - |
| Amortization Of Intangibles Income Statement | $1,720,000 | $0 | $0 | - |
| Gross Profit | $1,493,180,000 | $1,023,158,000 | $492,740,000 | $363,966,000 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-1.52 | $-1.53 | $-3.78 | $-5.57 |
| Basic EPS | $-1.52 | $-1.53 | $-3.78 | $-5.57 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-220,536,000 | $-148,078,000 | $-397,795,000 | $-520,800,000 |
| Reconciled Depreciation | $43,484,000 | $30,968,000 | $24,097,000 | $16,702,000 |
| EBITDA (Bullshit earnings) | $-220,536,000 | $-148,078,000 | $-397,795,000 | $-520,800,000 |
| EBIT | $-264,020,000 | $-179,046,000 | $-421,892,000 | $-537,502,000 |
| Diluted Average Shares | $136,721,000 | $124,718,000 | $114,997,000 | $98,408,000 |
| Basic Average Shares | $136,721,000 | $124,718,000 | $114,997,000 | $98,408,000 |
| Diluted NI Availto Com Stockholders | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Tax Provision | $-59,929,000 | $695,000 | $271,000 | $978,000 |
| Amortization | $1,720,000 | $0 | $0 | - |
| Research And Development | $624,110,000 | $404,138,000 | $320,678,000 | $316,415,000 |
| Selling General And Administration | $1,177,261,000 | $841,314,000 | $618,307,000 | $588,591,000 |
| Total Unusual Items | - | - | - | $0 |
| Total Unusual Items Excluding Goodwill | - | - | - | $0 |
| Gain On Sale Of Business | - | - | - | - |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,197,630,000 | $1,184,487,000 | $765,327,000 | $705,744,000 |
| Total Assets | $2,398,344,000 | $1,660,735,000 | $1,441,699,000 | $1,394,474,000 |
| Total Non Current Assets | $901,405,000 | $284,915,000 | $183,150,000 | $182,657,000 |
| Other Non Current Assets | $36,897,000 | $25,787,000 | $15,403,000 | $18,330,000 |
| Goodwill And Other Intangible Assets | $514,783,000 | $10,933,000 | - | - |
| Other Intangible Assets | $373,713,000 | $10,933,000 | - | - |
| Current Assets | $1,496,939,000 | $1,375,820,000 | $1,258,549,000 | $1,211,817,000 |
| Other Current Assets | $55,828,000 | $48,635,000 | $60,524,000 | $33,634,000 |
| Inventory | $68,443,000 | $44,744,000 | $40,759,000 | $35,406,000 |
| Receivables | $296,528,000 | $314,165,000 | $278,289,000 | $244,385,000 |
| Accounts Receivable | $296,528,000 | $314,165,000 | $278,289,000 | $244,385,000 |
| Allowance For Doubtful Accounts Receivable | $-8,018,000 | $-7,259,000 | $-6,481,000 | $-3,830,000 |
| Gross Accounts Receivable | $304,546,000 | $321,424,000 | $284,770,000 | $248,215,000 |
| Cash Cash Equivalents And Short Term Investments | $1,076,140,000 | $968,276,000 | $878,977,000 | $898,392,000 |
| Cash And Cash Equivalents | $1,076,140,000 | $945,587,000 | $642,095,000 | $466,091,000 |
| Restricted Cash | - | - | - | $86,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $214,377,000 | $187,118,000 | $441,993,000 | $446,219,000 |
| Long Term Debt And Capital Lease Obligation | $118,473,000 | $96,588,000 | $349,970,000 | $358,230,000 |
| Current Debt And Capital Lease Obligation | $95,904,000 | $90,530,000 | $92,023,000 | $87,989,000 |
| Current Debt | $80,323,000 | $80,362,000 | $80,402,000 | $80,350,000 |
| Long Term Debt | - | - | $282,945,000 | $281,653,000 |
| Other Current Borrowings | - | - | - | $80,350,000 |
| Net Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $685,931,000 | $465,315,000 | $676,372,000 | $688,730,000 |
| Total Non Current Liabilities Net Minority Interest | $244,703,000 | $121,270,000 | $369,098,000 | $378,231,000 |
| Other Non Current Liabilities | $11,687,000 | $7,844,000 | - | - |
| Tradeand Other Payables Non Current | $96,780,000 | $0 | - | - |
| Non Current Deferred Liabilities | $17,763,000 | $16,838,000 | $19,128,000 | $20,001,000 |
| Non Current Deferred Taxes Liabilities | $701,000 | $0 | - | - |
| Current Liabilities | $441,228,000 | $344,045,000 | $307,274,000 | $310,499,000 |
| Current Deferred Liabilities | $24,907,000 | $19,754,000 | $16,612,000 | $10,777,000 |
| Payables And Accrued Expenses | $218,307,000 | $160,371,000 | $129,537,000 | $148,775,000 |
| Payables | $63,101,000 | $39,338,000 | $18,729,000 | $35,467,000 |
| Other Payable | $21,580,000 | - | - | - |
| Total Tax Payable | $8,365,000 | $4,416,000 | $3,731,000 | $4,319,000 |
| Accounts Payable | $33,156,000 | $34,922,000 | $14,998,000 | $31,148,000 |
| Interest Payable | - | $0 | $1,078,000 | $1,078,000 |
| Income Tax Payable | - | - | - | $4,319,000 |
| Equity | ||||
| Common Stock Equity | $1,712,413,000 | $1,195,420,000 | $765,327,000 | $705,744,000 |
| Total Equity Gross Minority Interest | $1,712,413,000 | $1,195,420,000 | $765,327,000 | $705,744,000 |
| Stockholders Equity | $1,712,413,000 | $1,195,420,000 | $765,327,000 | $705,744,000 |
| Gains Losses Not Affecting Retained Earnings | $-258,000 | $-344,000 | $-3,085,000 | $-16,362,000 |
| Other Equity Adjustments | $-258,000 | $-344,000 | $-3,085,000 | $-16,362,000 |
| Retained Earnings | $-2,776,022,000 | $-2,567,862,000 | $-2,377,436,000 | $-1,942,635,000 |
| Other | ||||
| Ordinary Shares Number | $139,693,000 | $132,646,000 | $119,581,000 | $111,255,000 |
| Share Issued | $139,693,000 | $132,646,000 | $119,581,000 | $111,255,000 |
| Tangible Book Value | $1,197,630,000 | $1,184,487,000 | $765,327,000 | $705,744,000 |
| Invested Capital | $1,792,736,000 | $1,275,782,000 | $1,128,674,000 | $1,067,747,000 |
| Working Capital | $1,055,711,000 | $1,031,775,000 | $951,275,000 | $901,318,000 |
| Capital Lease Obligations | $134,054,000 | $106,756,000 | $78,646,000 | $84,216,000 |
| Total Capitalization | $1,712,413,000 | $1,195,420,000 | $1,048,272,000 | $987,397,000 |
| Additional Paid In Capital | $4,488,679,000 | $3,763,614,000 | $3,145,837,000 | $2,664,730,000 |
| Capital Stock | $14,000 | $12,000 | $11,000 | $11,000 |
| Common Stock | $14,000 | $12,000 | $11,000 | $11,000 |
| Non Current Deferred Revenue | $17,062,000 | $16,838,000 | $19,128,000 | $20,001,000 |
| Long Term Capital Lease Obligation | $118,473,000 | $96,588,000 | $67,025,000 | $76,577,000 |
| Current Deferred Revenue | $24,907,000 | $19,754,000 | $16,612,000 | $10,777,000 |
| Current Capital Lease Obligation | $15,581,000 | $10,168,000 | $11,621,000 | $7,639,000 |
| Line Of Credit | $80,323,000 | $80,362,000 | $80,402,000 | $80,350,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $92,603,000 | $62,114,000 | $45,857,000 | $44,010,000 |
| Current Provisions | $9,507,000 | $11,276,000 | $23,245,000 | $18,948,000 |
| Current Accrued Expenses | $155,206,000 | $121,033,000 | $110,808,000 | $113,308,000 |
| Goodwill | $141,070,000 | $0 | - | - |
| Net PPE | $349,725,000 | $248,195,000 | $167,747,000 | $164,327,000 |
| Accumulated Depreciation | $-111,078,000 | $-78,416,000 | $-56,293,000 | $-35,698,000 |
| Gross PPE | $460,803,000 | $326,611,000 | $224,040,000 | $200,025,000 |
| Leases | $62,152,000 | $48,569,000 | $38,999,000 | $29,747,000 |
| Construction In Progress | $94,016,000 | $58,461,000 | $29,392,000 | $25,370,000 |
| Other Properties | $108,541,000 | $86,149,000 | $56,537,000 | $71,874,000 |
| Machinery Furniture Equipment | $196,094,000 | $133,432,000 | $99,112,000 | $73,034,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $0 | $22,689,000 | $236,882,000 | $432,301,000 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $76,113,000 | $58,746,000 | $-286,154,000 | $-479,198,000 |
| Operating Activities | ||||
| Operating Cash Flow | $215,301,000 | $135,664,000 | $-246,955,000 | $-431,501,000 |
| Cash Flow From Continuing Operating Activities | $215,301,000 | $135,664,000 | $-246,955,000 | $-431,501,000 |
| Operating Gains Losses | $-3,218,000 | $462,000 | $265,000 | $904,000 |
| Investing Activities | ||||
| Capital Expenditure | $-139,188,000 | $-76,918,000 | $-39,199,000 | $-47,697,000 |
| Investing Cash Flow | $-132,209,000 | $137,624,000 | $168,498,000 | $330,338,000 |
| Cash Flow From Continuing Investing Activities | $-132,209,000 | $137,624,000 | $168,498,000 | $330,338,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $235,441,000 | $433,192,000 |
| Financing Cash Flow | $47,461,000 | $30,204,000 | $254,461,000 | $482,640,000 |
| Cash Flow From Continuing Financing Activities | $47,461,000 | $30,204,000 | $254,461,000 | $482,640,000 |
| Net Other Financing Charges | $-112,000 | - | - | - |
| Net Common Stock Issuance | $0 | $0 | $235,441,000 | $433,192,000 |
| Common Stock Issuance | $0 | $0 | $235,441,000 | $433,192,000 |
| Other | ||||
| Repayment Of Debt | $0 | $-82,000 | $0 | $0 |
| Interest Paid Supplemental Data | $4,069,000 | $7,897,000 | $11,346,000 | $8,060,000 |
| Income Tax Paid Supplemental Data | $499,000 | $1,307,000 | $295,000 | $549,000 |
| End Cash Position | $1,076,140,000 | $945,587,000 | $642,095,000 | $466,091,000 |
| Beginning Cash Position | $945,587,000 | $642,095,000 | $466,091,000 | $84,614,000 |
| Changes In Cash | $130,553,000 | $303,492,000 | $176,004,000 | $381,477,000 |
| Proceeds From Stock Option Exercised | $47,573,000 | $30,286,000 | $19,020,000 | $19,448,000 |
| Net Issuance Payments Of Debt | $0 | $-82,000 | $0 | $30,000,000 |
| Net Long Term Debt Issuance | $0 | $-82,000 | $0 | $30,000,000 |
| Long Term Debt Payments | $0 | $-82,000 | $0 | $0 |
| Net Investment Purchase And Sale | $23,000,000 | $214,542,000 | $207,697,000 | $378,035,000 |
| Sale Of Investment | $23,000,000 | $339,222,000 | $306,000,000 | $464,982,000 |
| Purchase Of Investment | $0 | $-124,680,000 | $-98,303,000 | $-86,947,000 |
| Net Business Purchase And Sale | $-16,021,000 | $0 | $0 | - |
| Purchase Of Business | $-16,021,000 | $0 | $0 | - |
| Net Intangibles Purchase And Sale | $-33,000,000 | $-10,495,000 | $0 | $0 |
| Purchase Of Intangibles | $-33,000,000 | $-10,495,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-106,188,000 | $-66,423,000 | $-39,199,000 | $-47,697,000 |
| Purchase Of PPE | $-106,188,000 | $-66,423,000 | $-39,199,000 | $-47,697,000 |
| Change In Working Capital | $10,045,000 | $2,141,000 | $-47,953,000 | $-83,150,000 |
| Change In Other Working Capital | $-58,047,000 | $852,000 | $4,962,000 | $2,056,000 |
| Change In Other Current Liabilities | $-19,751,000 | $-16,819,000 | $-12,448,000 | $-9,999,000 |
| Change In Other Current Assets | $4,229,000 | $0 | $8,354,000 | $622,000 |
| Change In Payables And Accrued Expense | $92,367,000 | $47,162,000 | $16,508,000 | $56,181,000 |
| Change In Accrued Expense | $91,614,000 | $33,952,000 | $31,966,000 | $50,719,000 |
| Change In Payable | $753,000 | $13,210,000 | $-15,458,000 | $5,462,000 |
| Change In Account Payable | $753,000 | $13,210,000 | $-15,458,000 | $5,462,000 |
| Change In Prepaid Assets | $-8,634,000 | $10,807,000 | $-26,072,000 | $-1,202,000 |
| Change In Inventory | $-20,871,000 | $-3,985,000 | $-5,353,000 | $-8,497,000 |
| Change In Receivables | $20,752,000 | $-35,876,000 | $-33,904,000 | $-122,311,000 |
| Changes In Account Receivables | $20,752,000 | $-35,876,000 | $-33,904,000 | $-122,311,000 |
| Other Non Cash Items | $18,714,000 | $18,709,000 | $18,542,000 | $24,621,000 |
| Stock Based Compensation | $354,404,000 | $274,428,000 | $191,808,000 | $152,384,000 |
| Amortization Of Securities | $32,000 | $-618,000 | $1,087,000 | $4,837,000 |
| Depreciation Amortization Depletion | $43,484,000 | $30,968,000 | $24,097,000 | $16,702,000 |
| Depreciation And Amortization | $43,484,000 | $30,968,000 | $24,097,000 | $16,702,000 |
| Amortization Cash Flow | $1,720,000 | $0 | $0 | - |
| Amortization Of Intangibles | $1,720,000 | $0 | $0 | - |
| Depreciation | $41,764,000 | $30,968,000 | $24,097,000 | - |
| Gain Loss On Investment Securities | $-3,235,000 | - | - | $906,000 |
| Net Foreign Currency Exchange Gain Loss | $17,000 | $462,000 | $265,000 | $-2,000 |
| Net Income From Continuing Operations | $-208,160,000 | $-190,426,000 | $-434,801,000 | $-547,799,000 |
| Issuance Of Debt | - | $0 | $0 | $30,000,000 |
| Long Term Debt Issuance | - | $0 | $0 | $30,000,000 |
| Net Short Term Debt Issuance | - | - | $0 | $30,000,000 |
| Short Term Debt Issuance | - | - | $0 | $30,000,000 |
| Unrealized Gain Loss On Investment Securities | - | - | - | $-2,000 |
| Provisionand Write Offof Assets | - | - | - | $1,770,000 |
| Sale Of Business | - | - | - | - |
| Asset Impairment Charge | - | - | - | - |
| Gain Loss On Sale Of Business | - | - | - | - |
Fetched: 2026-06-22